StonvexLoading…
StonvexCore line items from AMWL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $249.32M | $254.36M | $259.05M | $277.19M |
Operating Income | $-105.27M | $-217.53M | $-692.14M | $-275.85M |
Net Income | $-95.70M | $-208.14M | $-675.16M | $-270.43M |
EPS (Diluted) | $-5.96 | $-13.88 | $-47.50 | $-19.72 |
Total Assets | $323.79M | $435.97M | $589.71M | $1.22B |
Total Liabilities | $76.00M | $119.72M | $109.52M | $133.71M |
Cash & Equivalents | $182.33M | $228.32M | $372.04M | $538.55M |
Free Cash Flow OCF − CapEx | $-65.97M | $-127.46M | $-148.53M | $-192.62M |
Shares Outstanding | 16.43M | 15.57M | 288.49M | 277.14M |